Literature DB >> 3159021

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

C L Masters, G Simms, N A Weinman, G Multhaup, B L McDonald, K Beyreuther.   

Abstract

We have purified and characterized the cerebral amyloid protein that forms the plaque core in Alzheimer disease and in aged individuals with Down syndrome. The protein consists of multimeric aggregates of a polypeptide of about 40 residues (4 kDa). The amino acid composition, molecular mass, and NH2-terminal sequence of this amyloid protein are almost identical to those described for the amyloid deposited in the congophilic angiopathy of Alzheimer disease and Down syndrome, but the plaque core proteins have ragged NH2 termini. The shared 4-kDa subunit indicates a common origin for the amyloids of the plaque core and of the congophilic angiopathy. There are superficial resemblances between the solubility characteristics of the plaque core and some of the properties of scrapie infectivity, but there are no similarities in amino acid sequences between the plaque core and scrapie polypeptides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159021      PMCID: PMC397973          DOI: 10.1073/pnas.82.12.4245

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  7 in total

1.  Abnormal fibrils from scrapie-infected brain.

Authors:  P A Merz; R A Somerville; H M Wisniewski; K Iqbal
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

2.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

3.  Purification and structural studies of a major scrapie prion protein.

Authors:  S B Prusiner; D F Groth; D C Bolton; S B Kent; L E Hood
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

4.  The isolation and amino acid composition of senile plaque core protein.

Authors:  D Allsop; M Landon; M Kidd
Journal:  Brain Res       Date:  1983-01-24       Impact factor: 3.252

5.  Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea.

Authors:  D J Selkoe; Y Ihara; F J Salazar
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

6.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

7.  Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies.

Authors:  C L Masters; D C Gajdusek; C J Gibbs
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

  7 in total
  1108 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  The tangled biology of tau.

Authors:  K C Wilhelmsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

4.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption.

Authors:  C M Yip; J McLaurin
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

5.  Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein.

Authors:  S F Lichtenthaler; R Wang; H Grimm; S N Uljon; C L Masters; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

Authors:  Anthony R White; Gerd Multhaup; Denise Galatis; William J McKinstry; Michael W Parker; Rüdiger Pipkorn; Konrad Beyreuther; Colin L Masters; Roberto Cappai
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

7.  Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene.

Authors:  W W Quitschke; M J Taheny; L J Fochtmann; A A Vostrov
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

Review 8.  Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.

Authors:  Xiaoyun Guo; Wenying Qiu; Rolando Garcia-Milian; Xiandong Lin; Yong Zhang; Yuping Cao; Yunlong Tan; Zhiren Wang; Jing Shi; Jijun Wang; Dengtang Liu; Lisheng Song; Yifeng Xu; Xiaoping Wang; Na Liu; Tao Sun; Jianming Zheng; Justine Luo; Huihao Zhang; Jianying Xu; Longli Kang; Chao Ma; Kesheng Wang; Xingguang Luo
Journal:  J Neural Transm (Vienna)       Date:  2017-08-02       Impact factor: 3.575

9.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Authors:  S Waelter; A Boeddrich; R Lurz; E Scherzinger; G Lueder; H Lehrach; E E Wanker
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 10.  Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development.

Authors:  Joanna L Jankowsky; Alena Savonenko; Gabriele Schilling; Jiou Wang; Guilian Xu; David R Borchelt
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.